Gene · 2273
Papers1,852
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,852
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo. | Cell Rep Methods | 2023 | 37949066 | PubTator, text mining | PubMed |
| Exploring the diversity of AVPR2 in Primates and its evolutionary implications. | Genet Mol Biol | 2023 | 37930141 | PubTator, text mining | PubMed |
| Notch Signaling Regulates Mouse Perivascular Adipose Tissue Function via Mitochondrial Pathways. | Genes (Basel) | 2023 | 37895313 | PubTator, text mining | PubMed |
| FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design. | Nat Commun | 2023 | 37884534 | PubTator, text mining | PubMed |
| A SLiM-dependent conformational change in baculovirus IE1 controls its focus formation ability. | J Gen Virol | 2023 | 37877992 | PubTator, text mining | PubMed |
| Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions. | Genome Med | 2023 | 37872640 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in skeletal muscle wasting. | J Cachexia Sarcopenia Muscle | 2023 | 37867162 | PubTator, text mining | PubMed |
| Network medicine approaches for identification of novel prognostic systems biomarkers and drug candidates for papillary thyroid carcinoma. | J Cell Mol Med | 2023 | 37859510 | PubTator, text mining | PubMed |
| Time-sequential fibroblast-to-myofibroblast transition in elastin-variable 3D hydrogel environments by collagen networks. | Biomater Res | 2023 | 37848974 | PubTator, text mining | PubMed |
| Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies. | Diagnostics (Basel) | 2023 | 37835823 | PubTator, text mining | PubMed |
| Role of Caveolae family-related proteins in the development of breast cancer. | Front Mol Biosci | 2023 | 37828916 | PubTator, text mining | PubMed |
| Insights into the liver-eyes connections, from epidemiological, mechanical studies to clinical translation. | J Transl Med | 2023 | 37817192 | PubTator, text mining | PubMed |
| Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review. | Indian J Med Res | 2023 | 37787257 | PubTator, text mining | PubMed |
| Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies. | EBioMedicine | 2023 | 37769433 | PubTator, text mining | PubMed |
| Discovery and Potential Utility of a Novel Non-Invasive Ocular Delivery Platform. | Pharmaceutics | 2023 | 37765311 | PubTator, text mining | PubMed |
| Repeated pulmonary nodules as the primary symptom of familial hemophagocytic lymphohistiocytosis in adults: a case report and review. | J Int Med Res | 2023 | 37756585 | PubTator, text mining | PubMed |
| Accurate Classification of Non-ischemic Cardiomyopathy. | Curr Cardiol Rep | 2023 | 37721634 | PubTator, text mining | PubMed |
| Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets. | Nat Commun | 2023 | 37704626 | PubTator, text mining | PubMed |
| Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19. | bioRxiv | 2023 | 37693408 | PubTator, text mining | PubMed |
| Upregulation of the Four and a Half LIM Domains 1 linked with familial venous dysplasia in a familial genetic examination. | Am J Transl Res | 2023 | 37692954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2273/papers?page=7